From: Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
Surgery alone | NT + Surgery | p-Value | |
---|---|---|---|
(n = 170) | (n = 33) | ||
T1 | 30 (18) | 0 | |
T2 | 29 (17) | 2 (6) | 0.0007 |
T3 | 101 (59) | 29 (88) | |
T4 | 10 (6) | 2 (6) | |
N0 | 70 (41) | 8 (24) | 0.0795 |
N1 | 100 (59) | 25 (76) |